logo

Context Therapeutics Inc. (CNTX)



Trade CNTX now with
  Date
  Headline
8/2/2022 10:07:03 AM Context, Menarini To Evaluate ONA-XR And Elacestrant Combination; Initiates Phase 1b/2 Trial In Q4
10/19/2021 10:23:02 PM Context Therapeutics Prices IPO Of 5 Mln Shares At $5.00/shr